4//SEC Filing
AMGEN INC 4
Accession 0001127602-15-026495
$AMGNCIK 0000318154operating
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 7:46 PM ET
Size
5.2 KB
Accession
0001127602-15-026495
Insider Transaction Report
Form 4
AMGEN INCAMGN
de Carbonnel Francois
Director
Transactions
- Sale
Common Stock
2015-08-31$153.84/sh−5,000$769,192→ 15,150 total
Footnotes (2)
- [F1]$153.8384 is an average price. The prices ranged from $153.742341 to $153.997975 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F2]These shares include 154 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000318154
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 7:46 PM ET
- Size
- 5.2 KB